Table 3.
Haplotype frequency distribution of the MMP-2 and -9 genes, and association with stroke outcome.
| Whole sample | Ischemic subset | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene | Haplotype | Haplotype frequency | Good recovery (%) | Poor recovery (%) | χ2 | P | Haplotype frequency | Good recovery (%) | Poor recovery (%) | χ2 | P |
| MMP-2 | rs11643630-rs243866-rs243865 | 0.200 | 17.2 | 22.7 | 5.150 | 0.0233 | 0.198 | 16.8 | 23.5 | 6.125 | 0.0133 |
| TAT | |||||||||||
| MMP-2 | rs1477017-rs17301608-rs1132896-rs1053605-rs2241145-rs243849-rs243842-rs183112 | 0.011 | 1.8 | 0.4 | 4.776 | 0.0289 | 0.014 | 2.1 | 0.6 | 3.372 | 0.0663 |
| ACGCGTTG | |||||||||||
| MMP-9 | rs8113877-rs3918253-rs2236416 | 0.034 | 4.8 | 1.9 | 7.403 | 0.0065 | 0.038 | 4.9 | 2.4 | 3.680 | 0.0551 |
| TCA | |||||||||||
Only haplotypes with significant association results are presented.